Journal of Leukemia and Lymphoma
Published by Chinese Medical Journals Publishing House Co.Ltd
ISSN : 1009-9921
Abbreviation : J. Leuk. Lymphoma
Aims & Scope
Journal of Leukemia & Lymphoma, openly published since 1992, is a specialized academic journal that carries articles on the scientific profits and academic development of malignant tumors, involving the fields of medicine, chemistry, biology, etc.
The aims are to launch academic exchange, to spread the scientific results, to reflect the development trends, and to lead the research directions.
The journal focuses on both the basic research and clinical work, and combines popularization with the raising of standards, in order to promote the national development of cancer prevention and treatment, and to raise the healthy awareness of the people.
It is intended for high and middle ranking medical staffs.
The editorial board consists of more than 100 well-known oncologists from home and abroad including the academicians both from the Chinese Academy of Science and the Chinese Academy of Engineering.
View Aims & ScopeMetrics & Ranking
Journal Rank
Year | Value |
---|---|
2024 | 29124 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 28 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.105 |
Quartile
Year | Value |
---|---|
2024 | Q4 |
h-index
Year | Value |
---|---|
2024 | 6 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.